Filters
Investing in R&D to drive high-value pipeline delivery
Insight, Report Case Study
Investing in manufacturing excellence at Hikma
Insight, Report Case Study
Investing in MENA to expand access and drive growth
Insight, Report Case Study
Investing in strategic partnerships driving growth in the US and MENA
Insight, Report Case Study
Investing in the development of our people for long‑term growth
Insight, Report Case Study
Hikma launches authorised generic of Nucynta® ER (tapentadol) extended-release in the US
Press Release, Product
Hikma R&D. Innovation in formulation development. Meet Hamza Qassim
Story, Life at Hikma
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
Press Release, Financial Results
Hikma launches authorised generic of Nucynta® (tapentadol) in the US
Press Release, Product
New
Inspired at Hikma. Meet Ana Santos Perez
Story, Life at Hikma
Hikma R&D. Innovation in clinical research. Meet Hiba Kamal
Story, Life at Hikma
New
Hikma announces launch of Enoby™ (denosumab- qbde) and Xtrenbo™ (denosumab- qbde) referencing Prolia® and Xgeva® respect...
Press Release, Product
New
Hikma achieves B scores in Climate Change and Water Security in 2025 CDP assessment
Press Release, Corporate
New
Exploring partnership opportunities with Hikma Pharmaceuticals. A Q&A with, Faisal Darwazeh VP of Group Business Develop...
Insight, Corporate